UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ublituximab (TG‐1101), a novel glycoengineered anti‐CD20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymphocytic leukaemia: results of a phase 2 trial

British journal of haematology, 2017-02, Vol.176 (3), p.412-420

2017

Volltextzugriff (PDF)

Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma

Cancer, 2011-05, Vol.117 (10), p.2112-2119

2011

Volltextzugriff (PDF)

MAGNIFY: Phase IIIb Randomized Study of Lenalidomide Plus Rituximab (R2) Followed By Lenalidomide Vs. Rituximab Maintenance in Subjects with Relapsed/Refractory Follicular, Marginal Zone, or Mantle Cell Lymphoma

Blood, 2016-12, Vol.128 (22), p.1798-1798

2016

Volltextzugriff (PDF)

Ublituximab ( TG ‐1101), a novel glycoengineered anti‐ CD 20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymphocytic leukaemia: results of a phase 2 trial

British journal of haematology, 2017-02, Vol.176 (3), p.412-420

2017

Volltextzugriff (PDF)

Ublituximab (TG-1101), a Novel Glycoengineered Anti-CD20 Monoclonal Antibody, in Combination with Ibrutinib Is Highly Active in Patients with Relapsed and/or Refractory Mantle Cell Lymphoma; Results of a Phase II Trial

Blood, 2015-12, Vol.126 (23), p.3980-3980

2015

Volltextzugriff (PDF)

Ublituximab (TG-1101), a Novel Glycoengineered Anti-CD20 Monoclonal Antibody, in Combination with Ibrutinib Is Highly Active in Patients with Relapsed and/or Refractory CLL and MCL; Results of a Phase II Trial

Blood, 2014-12, Vol.124 (21), p.4679-4679

2014

Volltextzugriff (PDF)

Phase II study of dasatinib in the treatment of head and neck squamous cell carcinoma (HNSCC)

Cancer, 2010-11, Vol.117 (10), p.2112-2119

2010

Volltextzugriff (PDF)

LMO2 and Bcl-6 Expression in Diffuse Large B-Cell Lymphoma Predict Overall Survival in R-CHOP Treated Patients

Blood, 2008-11, Vol.112 (11), p.5304-5304

2008

Volltextzugriff (PDF)

Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial

PloS one, 2017-02, Vol.12 (2), p.e0170547-e0170547

2017

Volltextzugriff (PDF)

The Immunology of Epstein-Barr Virus-Induced Disease

Annual review of immunology, 2015-03, Vol.33 (1), p.787-821

2015

Volltextzugriff (PDF)

Antimicrobial Properties of a Chitosan Dextran-Based Hydrogel for Surgical Use

Antimicrobial Agents and Chemotherapy, 2012-01, Vol.56 (1), p.280-287

2012

Volltextzugriff (PDF)

Antimicrobial Properties of Tris(homoleptic) Ruthenium(II) 2‑Pyridyl-1,2,3-triazole “Click” Complexes against Pathogenic Bacteria, Including Methicillin-Resistant Staphylococcus aureus (MRSA)

Inorganic chemistry, 2016-10, Vol.55 (19), p.9767-9777

2016

Volltextzugriff (PDF)

Conditional vulnerability of plant diversity to atmospheric nitrogen deposition across the United States

Proceedings of the National Academy of Sciences - PNAS, 2016-04, Vol.113 (15), p.4086-4091

2016

Volltextzugriff (PDF)

Reducing the Oxidation Level of Dextran Aldehyde in a Chitosan/Dextran-Based Surgical Hydrogel Increases Biocompatibility and Decreases Antimicrobial Efficacy

International journal of molecular sciences, 2015-06, Vol.16 (6), p.13798-13814

2015

Volltextzugriff (PDF)

In vitro biocompatibility and cellular interactions of a chitosan/dextran-based hydrogel for postsurgical adhesion prevention

Journal of biomedical materials research. Part B, Applied biomaterials, 2015-02, Vol.103 (2), p.332-341

2015

Volltextzugriff (PDF)

Induction of Robust Cellular and Humoral Virus-Specific Adaptive Immune Responses in Human Immunodeficiency Virus-Infected Humanized BLT Mice

Journal of Virology, 2009-07, Vol.83 (14), p.7305-7321

2009

Volltextzugriff (PDF)

Pathogenic DPYD Variants and Treatment‐Related Mortality in Patients Receiving Fluoropyrimidine Chemotherapy: A Systematic Review and Meta‐Analysis

The oncologist (Dayton, Ohio), 2021-12, Vol.26 (12), p.1008-1016

2021

Volltextzugriff (PDF)

Synthesis, structure, stability and antimicrobial activity of a ruthenium(II) helicate derived from a bis-bidentate “click” pyridyl-1,2,3-triazole ligand

Inorganica Chimica Acta, 2015-01, Vol.425, p.1-6

2015

Volltextzugriff (PDF)

A dynamic covalent approach to [PtL] cages

Chemical communications (Cambridge, England), 2024-04, Vol.6 (32), p.432-435

2024

Volltextzugriff (PDF)

Effects of Community-Wide Teen Pregnancy Prevention Initiatives on Local Teen Birth Rates in the United States: A Synthetic Control Approach

Prevention science, 2024-04, Vol.25 (3), p.545-565

2024

Volltextzugriff (PDF)

Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion

Scientific reports, 2018-02, Vol.8 (1), p.2090-14, Article 2090

2018

Volltextzugriff (PDF)

Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2021-11, Vol.326 (17), p.1703

2021

Volltextzugriff (PDF)

Practical Approaches to Evaluating Progress and Outcomes in Community-Wide Teen Pregnancy Prevention Initiatives

Journal of adolescent health, 2017-03, Vol.60 (3), p.S63-S68

2017

Volltextzugriff (PDF)

A dynamic covalent approach to [PtnL2n]2n+ cages

Chemical communications (Cambridge, England), 2024-04, Vol.60 (32), p.4302-4305

2024

Volltextzugriff (PDF)

1 – 25 von 210

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(190)
Mit Volltextzugriff
(188)

Publikationsform

Sprache

Englisch
(210)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Ublituximab (TG‐1101), a novel glycoengineered anti‐CD20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymphocytic leukaemia: results of a phase 2 trial

Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma

MAGNIFY: Phase IIIb Randomized Study of Lenalidomide Plus Rituximab (R2) Followed By Lenalidomide Vs. Rituximab Maintenance in Subjects with Relapsed/Refractory Follicular, Marginal Zone, or Mantle Cell Lymphoma

Ublituximab ( TG ‐1101), a novel glycoengineered anti‐ CD 20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymphocytic leukaemia: results of a phase 2 trial

Ublituximab (TG-1101), a Novel Glycoengineered Anti-CD20 Monoclonal Antibody, in Combination with Ibrutinib Is Highly Active in Patients with Relapsed and/or Refractory Mantle Cell Lymphoma; Results of a Phase II Trial

Ublituximab (TG-1101), a Novel Glycoengineered Anti-CD20 Monoclonal Antibody, in Combination with Ibrutinib Is Highly Active in Patients with Relapsed and/or Refractory CLL and MCL; Results of a Phase II Trial

Phase II study of dasatinib in the treatment of head and neck squamous cell carcinoma (HNSCC)

LMO2 and Bcl-6 Expression in Diffuse Large B-Cell Lymphoma Predict Overall Survival in R-CHOP Treated Patients

Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial

The Immunology of Epstein-Barr Virus-Induced Disease

Antimicrobial Properties of a Chitosan Dextran-Based Hydrogel for Surgical Use

Antimicrobial Properties of Tris(homoleptic) Ruthenium(II) 2‑Pyridyl-1,2,3-triazole “Click” Complexes against Pathogenic Bacteria, Including Methicillin-Resistant Staphylococcus aureus (MRSA)

Conditional vulnerability of plant diversity to atmospheric nitrogen deposition across the United States

Reducing the Oxidation Level of Dextran Aldehyde in a Chitosan/Dextran-Based Surgical Hydrogel Increases Biocompatibility and Decreases Antimicrobial Efficacy

In vitro biocompatibility and cellular interactions of a chitosan/dextran-based hydrogel for postsurgical adhesion prevention

Induction of Robust Cellular and Humoral Virus-Specific Adaptive Immune Responses in Human Immunodeficiency Virus-Infected Humanized BLT Mice

Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study

Pathogenic DPYD Variants and Treatment‐Related Mortality in Patients Receiving Fluoropyrimidine Chemotherapy: A Systematic Review and Meta‐Analysis

Synthesis, structure, stability and antimicrobial activity of a ruthenium(II) helicate derived from a bis-bidentate “click” pyridyl-1,2,3-triazole ligand

A dynamic covalent approach to [PtL] cages

Effects of Community-Wide Teen Pregnancy Prevention Initiatives on Local Teen Birth Rates in the United States: A Synthetic Control Approach

Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion

Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial

Practical Approaches to Evaluating Progress and Outcomes in Community-Wide Teen Pregnancy Prevention Initiatives

A dynamic covalent approach to [PtnL2n]2n+ cages

Suchergebnisse filtern